Lead-Related Complications

Cardiovascular implantable electronic devices (CIEDs) have become more widespread in use over the last decade, owing to the aging population and expanding indications. The weakest link in the CIED system is the transvenous leads. This review summarizes the current issues with leads including occurrence of complications, lead-related advisories and their management.

[1]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[2]  M. Gold,et al.  Meta-Analysis of Bleeding Complications Associated With Cardiac Rhythm Device Implantation , 2012, Circulation. Arrhythmia and electrophysiology.

[3]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[4]  C. Ervin,et al.  Lead extraction in the contemporary setting: the LExICon study: an observational retrospective study of consecutive laser lead extractions. , 2010, Journal of the American College of Cardiology.

[5]  G. Lamas,et al.  Reduced Ejection Fraction, Sudden Cardiac Death, and Heart Failure Death in the Mode Selection Trial (MOST): Implications for Device Selection in Elderly Patients with Sinus Node Disease , 2008, Journal of cardiovascular electrophysiology.

[6]  Jacques Victor,et al.  Risk Factors Related to Infections of Implanted Pacemakers and Cardioverter-Defibrillators: Results of a Large Prospective Study , 2007, Circulation.

[7]  Luca Segreti,et al.  Transvenous removal of pacing and implantable cardiac defibrillating leads using single sheath mechanical dilatation and multiple venous approaches: high success rate and safety in more than 2000 leads , 2008, European heart journal.

[8]  Maria Grazia Bongiorni,et al.  Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). , 2009, Heart rhythm.

[9]  W. Toff,et al.  Are Elderly Patients at Increased Risk of Complications Following Pacemaker Implantation? A Meta‐Analysis of Randomized Trials , 2012, Pacing and clinical electrophysiology : PACE.

[10]  Wojciech Zareba,et al.  Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.

[11]  A. Krahn,et al.  Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. , 2006, JAMA.

[12]  A. Skanes,et al.  Management of infections involving implanted cardiac electrophysiologic devices , 2008, Current treatment options in cardiovascular medicine.

[13]  Eugene Crystal,et al.  Predictors of Short-Term Complications After Implantable Cardioverter-Defibrillator Replacement: Results From the Ontario ICD Database , 2011, Circulation. Arrhythmia and electrophysiology.

[14]  A. Wilde,et al.  Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: A systematic review and meta-analysis of inappropriate shocks and complications. , 2016, Heart rhythm.

[15]  G. Naccarelli,et al.  Tricuspid Valve Incompetence Following Implantation of Ventricular Leads , 2015, Current Heart Failure Reports.

[16]  Thomas Kleemann,et al.  Annual Rate of Transvenous Defibrillation Lead Defects in Implantable Cardioverter-Defibrillators Over a Period of >10 Years , 2007, Circulation.

[17]  M Gent,et al.  Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. , 2000, Circulation.

[18]  A. Russo,et al.  Gender and outcomes after primary prevention implantable cardioverter-defibrillator implantation: Findings from the National Cardiovascular Data Registry (NCDR). , 2015, American heart journal.

[19]  A. Skanes,et al.  Arrhythmia device lead extraction: factors that necessitate laser assistance. , 2008, The Canadian journal of cardiology.

[20]  C. Byrd.  Chapter 21 – Managing Device-Related Complications and Transvenous Lead Extraction , 2007 .

[21]  Luca Segreti,et al.  Superior vena cava defibrillator coils make transvenous lead extraction more challenging and riskier. , 2013, Journal of the American College of Cardiology.

[22]  A. Moss,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. , 1996, The New England journal of medicine.

[23]  J. Healey,et al.  Complications Associated With Revision of Sprint Fidelis Leads: Report From the Canadian Heart Rhythm Society Device Advisory Committee , 2010, Circulation.

[24]  Eugene Crystal,et al.  Evaluation of early complications related to De Novo cardioverter defibrillator implantation insights from the Ontario ICD database. , 2010, Journal of the American College of Cardiology.

[25]  S. Greenberg,et al.  Performance of the St. Jude Medical Riata leads. , 2009, Heart rhythm.

[26]  E. Lonn,et al.  Tricuspid Valve Regurgitation Following Temporary or Permanent Endocardial Lead Insertion, and the Impact of Cardiac Resynchronization Therapy , 2014, The open cardiovascular medicine journal.

[27]  Michael P. Brunner,et al.  Clinical predictors of adverse patient outcomes in an experience of more than 5000 chronic endovascular pacemaker and defibrillator lead extractions. , 2014, Heart rhythm.

[28]  Daniel R. Frisch,et al.  16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. , 2011, Journal of the American College of Cardiology.

[29]  M. Keller,et al.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[30]  John L Sapp,et al.  Cardiac-resynchronization therapy for mild-to-moderate heart failure. , 2010, The New England journal of medicine.

[31]  David L Hayes,et al.  Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. , 2007, Journal of the American College of Cardiology.

[32]  J. Healey,et al.  Defibrillation Testing at the Time of ICD Insertion: An Analysis From the Ontario ICD Registry , 2010, Journal of cardiovascular electrophysiology.

[33]  M. Chung,et al.  Complication Rates Associated With Pacemaker or Implantable Cardioverter-Defibrillator Generator Replacements and Upgrade Procedures: Results From the REPLACE Registry , 2010, Circulation.